USPTO serial 90838769
LIGHTSHIP
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 31, 2023
- Examiner
- DE JONGE, KATHLEEN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LIGHTSHIP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
El Segundo, CA
El Segundo, CA
El Segundo, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Lindsay Cohen Schneider
Lindsay Cohen Schneider BRYAN CAVE LEIGHTON PAISNER LLP211 NORTH BROADWAY, SUITE 3600ST. LOUIS, MO 63102UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | downloadable computer application software for a cloud-based and web-based telemedicine platform for use in a clinical research; downloadable mobile applications to track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices | ACTIVE | Apr 1, 2020 |
| 035 | Business management services, namely, forecasting drug supplies for clinical trials for others; Business management services, namely, recruiting patients and volunteers for clinical trials for others; Business project management services for others in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs | ACTIVE | Feb 20, 2019 |
| 042 | Medical and scientific research in the nature of conducting clinical trials for others; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials for the development of pharmaceuticals and medical devices; Medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; Scientific consulting and research services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; Collection, calibration, analysis and reporting of medical and scientific data for research purposes in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; Virtual consulting services regarding medical and scientific research in relation to clinical trials only; Design and development of software for use in conducting research in clinical and non-clinical pharmaceutical and medical device and development studies; Providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; Providing medical and scientific research information in the fields of pharmaceuticals and clinical trials; Providing online non-downloadable software for tracking, monitoring, analyzing, generating and reporting patient information and healthcare statistics in clinical and non-clinical pharmaceutical and medical device and development studies | ACTIVE | Jul 2, 2019 |
| 044 | Providing telemedicine services to patients; collection, organization, analysis, and reporting of medical data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices for medical diagnosis and treatment purposes | ACTIVE | Jul 2, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Lightship, Inc.
- Other trademarks owned by Lightship, Inc.
- Other trademarks owned by Lightship, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LIGHTSHIP
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 26, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 13, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 12, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 11, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 11, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 13, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 13, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 22, 2021 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Sep 21, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 23, 2021 | NWAP | NEW APPLICATION ENTERED | — |